EAST GREENWICH, R.I., Sept. 27, 2017 -- In a newly published Inc. magazine article, Mark Clermont, president of Provant and its parent company Hooper Homes Inc. (OTCQX:HPHW), shared his insights on sleep coaching for workplace well-being programs. Provant, a national health and well-being leader, provides highly personalized health coaching on-site, by telephone, and digitally.
|
|||
In the article “Bosses are Finding that Sleep is Good for Business--And They're Hiring Coaches to Make It Happen,” Clermont notes that a growing number of companies are adding Provant’s health coaching services to their programming to help employees improve their quality of sleep. As a reason for the increase, he cites employers’ increasing recognition of the connections between sleep deprivation and chronic health conditions such as diabetes, heart disease, obesity and depression, and between quality of sleep and productivity.
Studies by several researchers over the past 13 years have found that sleep increases the risk for obesity by 650 percent, depression by 900 percent, diabetes by 70 percent, and heart attacks by 45 percent. In addition, according to a 2016 Rand study, poor sleep costs the American economy as much as $411 billion in productivity every year.
Provant’s experienced health coaches counsel on sleep and many other health behaviors in one-to-one sessions and in group settings. Recent on-site sleep coaching has brought Provant’s coaches to a variety of traditional and non-traditional settings, such as tugboats.
In addition to health coaching, Provant offers digital sleep therapy via its advanced platform. Through Provant’s well-being platform, companies can provide individuals with secure 24/7 access to expert sleep assessment and assistance.
Sleep coaching and digital sleep therapy are valuable and effective ways to help people attain better health, achieve high performance in their work and personal lives, and lower healthcare costs.
Provant’s innovative well-being services build dual bottom line success: They help employers achieve business goals while helping individuals achieve their own personal total health goals.
Companies can learn more about how to help their workforce improve their sleep and other lifestyle behaviors, and decrease health risks, can learn more by contacting Provant at [email protected].
About Provant
Provant, a wholly-owned subsidiary of Hooper Holmes, Inc. is a leader in comprehensive workplace well-being solutions with a growing, global presence. Provant partners with employers and brokers to improve member health and productivity and support healthcare cost management. Provant touches millions of lives by delivering customized well-being strategies and services on-site, telephonically and digitally, utilizing advanced data management technology. www.ProvantHealth.com
For further information:
Provant
Elaine Peterson
Senior Director, Marketing & Communications
(401) 234-0165


Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home
OpenAI Addresses Security Vulnerability in macOS App Certification Process
Bill Ackman Eyes New Fund to Bet Against Market Complacency
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit 



